Answers are grounded in this paper and cite their sources.
The assessment of the suitability of novel targets to intervention by different modalities, e.g. small molecules or antibodies, is increasingly seen as important in helping to select the most progressable targets at the outset of a drug discovery project.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: